Experience With Anifrolumab In Systemic Lupus Erythematosus Patients With Neurological Manifestations
May 2025
in “
The Journal of Rheumatology
”
Studysummary This study reviewed how Anifrolumab, though often used in real-world settings for SLE patients with neurological symptoms, showed varying effectiveness and required cautious monitoring for adverse effects like thrombocytopenia and cerebrovascular events.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jrheum.org →